BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 432,470 | $1,094,149 | 0.00% |
| Cutler Group LLC / CA | 6,200 | $15 | 0.00% |
| HRT FINANCIAL LP | 72,302 | $182 | 0.00% |
| Engineers Gate Manager LP | 22,264 | $56,328 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 39,600 | $100,188 | 0.00% |
| Crossmark Global Holdings, Inc. | 12,804 | $43 | 0.00% |
| Point72 Middle East FZE | 15,777 | $39,917 | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 200,000 | $506,000 | 0.00% |
| FMR LLC | 2,700,727 | $6,832,839 | 0.00% |
| AMERIPRISE FINANCIAL INC | 668,370 | $1,690,977 | 0.00% |
External links
This page lists BIOXCEL THERAPEUTICS INC's shareholders in Q3 2023. To view BIOXCEL THERAPEUTICS INC's shareholder history, click here.